Endometrial cancer is the most common gynaecological malignancy in high income
countries and its incidence is rising. Whilst most women with endometrial cancer are …

Endometrial cancer (EC) is the most common gynecological cancer, with annual incidence
rates in Western countries ranging between 15 and 25 per 100 000 women. About 15% to …

Aberrant expression of circRNAs has been proven to play a crucial role in the progression of
acute myeloid leukemia (AML); however, its regulatory mechanism remains unclear. Herein …

Introduction The European Society of Gynecologic Oncology/European Society of Radiation
Therapy and Oncology/European Society of Pathology (ESGO/ESTRO/ESP) committee …

The molecular characterization of endometrial carcinoma (EC) has recently been included in
the ESGO/ESTRO/ESP guidelines. The study aims to evaluate the impact of integrated …

Simple Summary In the past few years, the endometrial cancer field has been
revolutionized, following the integration of molecular classification into clinical practice …

Endometrial cancer (EC) is the most prevalent gynecological cancer in high‐income
countries. Its incidence is skyrocketing due to the increase in risk factors such as obesity …

Fetal alcohol spectrum disorders (FASDs) are leading causes of neurodevelopmental
disability but cannot be diagnosed early in utero. Because several microRNAs (miRNAs) are …

Endometrial cancer is the most common gynecological malignancy of the female
reproductive organs. Historically it was divided into type I and type II, until 2013 when the …

Aim Dedifferentiated endometrial adenocarcinoma (DEAC) is a rare, aggressive subtype,
accounting for 2% of all endometrial cancers. Poor survival in DEAC prompts the need for …